AnaptysBio, Inc. ANAB Biopharma Company — Operating Expenses

Other segment segments

Similar metrics at other companies

MANETotal Operating Expenses

$29.86M+131%

LHBiopharma Laboratory Services — Other Cost and Expense, Operating

$89.7M-0.3%

BMRNOther operating expenses

$3.96M+303%

BIIBTotal Operating Expenses

$2.1B-0.9%

CRNXTotal costs & expenses

$151.11M+35.2%

DNLITherapeutics Segment — Operating Expenses

$137.36M-5.6%

Questions, answered.

What is AnaptysBio, Inc.'s biopharma company — operating expenses?

AnaptysBio, Inc. (ANAB) reported biopharma company — operating expenses of $52.81M in Q1 2026.

How has AnaptysBio, Inc.'s biopharma company — operating expenses changed year-over-year?

AnaptysBio, Inc.'s biopharma company — operating expenses increased by 3.0% year-over-year, from $51.28M to $52.81M.

What does biopharma company — operating expenses mean?

This metric represents the aggregate of all costs incurred to run the business, primarily consisting of research and development and general administrative expenses. It provides a comprehensive view of the company's total cash burn rate from operations. Tracking this is essential for understanding the company's runway and the capital required to sustain its clinical development programs.